Prosecution Insights
Last updated: October 02, 2026

United States Department of Veterans Affairs

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

19 pending office actions • 13 art units • 19 examiners • 0 of 19 (0%) have an AI response strategy ready • 18 patents granted in the last 365 days

Analysis

The United States Department of Veterans Affairs currently manages 19 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 19 distinct examiners. This prosecution activity spans 13 distinct art units, indicating a range of technical sub-specialties within the biotechnology sector. The department's patent strategy involves a high degree of variety in the personnel reviewing its applications.

JONATHAN K NG is identified as the busiest examiner with 1 pending action. Because the portfolio contains 19 distinct examiners for each pending action, no individual examiner holds a larger share of the workload than any other. The use of 13 distinct art units for the pending actions suggests that several art units are handling multiple filings for the department. This count of examiners and 13 art units relative to the pending actions reflects the scale of the prosecution landscape. Each of the 19 pending office actions is being addressed by a different examiner, which may lead to varied outcomes across the Biotechnology & Pharmaceuticals portfolio. The pending actions are spread across the art units, showing that the department's innovations are evaluated by different examiners.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

19
Total Pending OAs
10
Non-Final OAs
8
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
1
Due this week
4
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 7 days (1)Due ≤ 30 days (4)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

9
Hard (47%)
6
Medium (32%)
4
Easy (21%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (5%)
§101 + other2 (11%)
§103 only6 (32%)
§112 only2 (11%)
Double-patenting only2 (11%)
Multi-statute (no §101)6 (32%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

8
Life Sciences
42% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
5% of docket
5
Mechanical / Eng
26% of docket
5
Business / Other
26% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

190 h
Manual time on pending OAs
38 h
Time saved (low, 20%)
66 h
Time saved (mid, 35%)
1.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NG, JONATHAN K 1 35.6% +14.0%
SCHAETZLE, KENNEDY 1 83.8% +8.1%
ATKINSON, JOSHUA ALEXANDER 1 52.4% +26.7%
LI, LARRY 1 100.0% +0.0%
GINES, GEORGE SAMUEL 1 69.5% +40.5%
HOLTZCLAW, MICHAEL T. 1 77.6% +16.0%
LEE, CHIHYI NMN 1 33.7% +60.8%
KOO, BENJAMIN K 1 57.1% +49.7%
MILLER, WILLIAM L 1 79.0% +14.8%
TOMASZEWSKI, MICHAEL 1 47.9% +22.2%

Hard Cases (9)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18276871 METHODS OF TREATING HYPOGONADOTROPIC HYPOGONADISM AND COGNITION IMPAIRMENT FOLLOWING A TRAUMATIC BRAIN INJURY JOHNSON, TIRONE DEREK 6d
18749726 Combination Therapy for Treating or Preventing Depression or Other Mood Diseases LEE, CHIHYI NMN 34d
19225745 FOUR-COMPARTMENT DIFFUSION MODEL OF INSULIN IN HUMANS NG, JONATHAN K —
19027952 Stereotactic Multifocal Recording And Stimulation Device And Methods Of Use SCHAETZLE, KENNEDY —
18907722 Disinfection System For Wheelchairs LI, LARRY —
18826930 Cuff For Providing Vagus Nerve Stimulation HOLTZCLAW, MICHAEL T. —
18737593 Medication Delivery Device KOO, BENJAMIN K —
18502774 Needle Assembly With Integrated Curvature Mechanism NICHOLS, CHARLES W —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18406868 CLINICAL SYSTEM INTEGRATION TOMASZEWSKI, MICHAEL 28d
18749726 Combination Therapy for Treating or Preventing Depression or Other Mood Diseases LEE, CHIHYI NMN 34d
19225745 FOUR-COMPARTMENT DIFFUSION MODEL OF INSULIN IN HUMANS NG, JONATHAN K —
18909697 Magneto-Patterned-Cell-Laden Hydrogel Materials and Methods of Making and Using Same ATKINSON, JOSHUA ALEXANDER —
18885039 Assistive Positioning Device For A Limb Of A Patient GINES, GEORGE SAMUEL —
18826930 Cuff For Providing Vagus Nerve Stimulation HOLTZCLAW, MICHAEL T. —
18737593 Medication Delivery Device KOO, BENJAMIN K —
18639153 Headstone Socket Preserver MILLER, WILLIAM L —

Top Art Units

Art UnitApps
1617 2
2884 1
3796 1
1628 1
3677 1
3681 1
3783 1
1675 1
1658 1
3798 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19225745 FOUR-COMPARTMENT DIFFUSION MODEL OF INSULIN IN HUMANS NG, JONATHAN K — §101DP Non-Final OA — Pending Jun 02, 2025
19027952 Stereotactic Multifocal Recording And Stimulation Device And Methods Of Use SCHAETZLE, KENNEDY — §101DP Final Rejection — Pending Jan 17, 2025
18909697 Magneto-Patterned-Cell-Laden Hydrogel Materials and Methods of Making and Using Same ATKINSON, JOSHUA ALEXANDER — DP Non-Final OA — Pending Oct 08, 2024
18907722 Disinfection System For Wheelchairs LI, LARRY — §102§103§112 Non-Final OA — Pending Oct 07, 2024
18885039 Assistive Positioning Device For A Limb Of A Patient GINES, GEORGE SAMUEL 2884 §103 Non-Final OA — Pending Sep 13, 2024
18826930 Cuff For Providing Vagus Nerve Stimulation HOLTZCLAW, MICHAEL T. 3796 §102§103 Final Rejection — Pending Sep 06, 2024
18749726 Combination Therapy for Treating or Preventing Depression or Other Mood Diseases LEE, CHIHYI NMN 1628 §103§112 Non-Final OA 34d Pending Jun 21, 2024
18737593 Medication Delivery Device KOO, BENJAMIN K — §102§103§112 Non-Final OA — Pending Jun 07, 2024
18639153 Headstone Socket Preserver MILLER, WILLIAM L 3677 §112 Non-Final OA — Pending Apr 18, 2024
18406868 CLINICAL SYSTEM INTEGRATION TOMASZEWSKI, MICHAEL 3681 §103 Final Rejection 28d Pending Jan 08, 2024
18502774 Needle Assembly With Integrated Curvature Mechanism NICHOLS, CHARLES W 3783 §102§103 Non-Final OA — Pending Nov 06, 2023
18276871 METHODS OF TREATING HYPOGONADOTROPIC HYPOGONADISM AND COGNITION IMPAIRMENT FOLLOWING A TRAUMATIC BRAIN INJURY JOHNSON, TIRONE DEREK 1675 §103§112 Final Rejection 6d Pending Aug 10, 2023
18038588 COMPOSITIONS AND METHODS OF INHIBITING THE BINDING OF PLASMA IGG AUTOANTIBODIES TO SEROTONIN 2A RECEPTOR KOMATSU, LI N 1658 DP Final Rejection 14d Pending May 24, 2023
18009608 METHODS AND SYSTEMS FOR DETERMINING AND CORRECTING IMAGING ARTIFACTS ROBINSON, NICHOLAS A 3798 §112 Final Rejection 26d Pending Dec 09, 2022
18074364 EVALUATION OF BRAIN TISSUE AND MATERIAL BASED ON A FRACTION-PRODUCT AND OPTICAL SPECTROSCOPY DO, AN H 1687 §101 Non-Final OA — Pending Dec 02, 2022
17910637 A Combined Inhibition of EGFR and NRF2 in The Treatment of Malignant Glioma HALVORSON, MARK 1646 §103Other Final Rejection 2d overdue Pending Sep 09, 2022
17779865 METHODS OF USING SOLUBLE SOLID DISPERSIONS OF RIFAXIMIN MEYERS, ELIZABETH ANNE 1617 §103 Non-Final OA 13d Pending May 25, 2022
17639265 LIPOSOMAL TROPONOID COMPOUND FORMULATIONS PIPIC, ALMA 1617 §103 Non-Final OA — Pending Feb 28, 2022
17288849 COMPOSITIONS AND METHODS FOR SELECTING BIALLELIC GENE EDITING DUNN, MCKENZIE A 1678 §103 Final Rejection 88d overdue Pending Apr 26, 2021

Managing United States Department of Veterans Affairs's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month